Abstract
Androgenetic Alopecia is a genetically predetermined disorder resulting in hair loss from an excessive sensitivity to androgens. Several treatment options have been investigated for androgenetic alopecia, yet only topical minoxidil and finasteride have received approval from the US Food and Drug Administration. This review article examines and evaluates the efficacy of new, cutting-edge techniques for treating AGA, including Low-Level Laser Therapy, Platelet Rich Plasma Therapy, Micro needling, and Topical Growth Factors and Peptides. Several essential factors are stimulated by minoxidil, including vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), and insulin-like growth factor (IGF)-1. IGF-1 also plays a significant role in regulating follicular differentiation, which makes it a vital regulator of hair follicle development and function. Low-level laser therapy (LLLT) uses low-intensity light at red or near-infrared wavelengths to induce changes in cellular activity, which improves blood circulation, reduces inflammation, and boosts cellular energy, ultimately leading to improved hair follicle density and diameter. Platelet-rich plasma therapy (PRP) is used in dermatology for acne scar treatment, lipid transplantation, wound healing, and hair regeneration. It involves a centrifugation process that increases the platelet concentration and reduces the red blood cell ratio. Micro needling is a minimally invasive procedure that stimulates the production of collagen, growth factors, and neovascularization, which promotes tissue rejuvenation. It is most utilized for individuals who are unable to achieve successful results using medical therapy. These approaches have shown positive outcomes in terms of hair regrowth, improved hair density, increased hair shaft thickness, and patient satisfaction.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.